![Gilmore O’Neill](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gilmore O’Neill
Vorstandsvorsitzender bei
EDITAS MEDICINE, INC.
Vermögen: 859 163 $ am 31.05.2026
Profil
Gilmore ONeill bekleidet die Position des Chief Medical Officer & Executive Vice President bei Sarepta Therapeutics, Inc. Dr. ONeill ist außerdem Mitglied des Vorstands des Massachusetts Biotechnology Council und von Unity Biotechnology, Inc. sowie Mitglied der American Academy of Neurology. In seiner früheren Karriere hatte er die Position des Senior Vice President bei Biogen, Inc. inne. Gilmore ONeill erwarb einen Bachelor-Abschluss am University College Dublin und einen Master-Abschluss an der Harvard University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 03.06.2026 | 248’313 ( 0.16% ) | 859 163 $ | 31.05.2026 |
Aktive Positionen von Gilmore O’Neill
| Unternehmen | Position | Beginn |
|---|---|---|
| EDITAS MEDICINE, INC. | Vorstandsvorsitzender | 01.06.2022 |
American Academy of Neurology
 American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services Operates a professional society which represents neurologists and neuroscientists | Corporate Officer/Principal | - |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Gilmore O’Neill
| Unternehmen | Position | Ende |
|---|---|---|
| UNITY BIOTECHNOLOGY, INC. | Direktor/Vorstandsmitglied | 27.06.2025 |
| APTINYX | Direktor/Vorstandsmitglied | 14.04.2023 |
| SAREPTA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 17.11.2021 |
| BIOGEN INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2018 |
| APTINYX | Direktor/Vorstandsmitglied | - |
Ausbildung von Gilmore O’Neill
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
84
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University College Dublin
 University College Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Commercial Services |
American Academy of Neurology
American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services Operates a professional society which represents neurologists and neuroscientists | Commercial Services |
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
Aptinyx, Inc.
 Aptinyx, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies to treat disorders of the brain and nervous system | Health Technology |
Unity Biotechnology, Inc.
 Unity Biotechnology, Inc. BiotechnologyHealth Technology Engages in the research and development of therapeutics to extend the human healthspan | Health Technology |
